<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2017-05-10" version="198">
<accession>Q14289</accession>
<accession>D3DST0</accession>
<accession>Q13475</accession>
<accession>Q14290</accession>
<accession>Q16709</accession>
<accession>Q6PID4</accession>
<name>FAK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein-tyrosine kinase 2-beta</fullName>
<ecNumber>2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Calcium-dependent tyrosine kinase</fullName>
<shortName>CADTK</shortName>
</alternativeName>
<alternativeName>
<fullName>Calcium-regulated non-receptor proline-rich tyrosine kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Cell adhesion kinase beta</fullName>
<shortName>CAK-beta</shortName>
<shortName>CAKB</shortName>
</alternativeName>
<alternativeName>
<fullName>Focal adhesion kinase 2</fullName>
<shortName>FADK 2</shortName>
</alternativeName>
<alternativeName>
<fullName>Proline-rich tyrosine kinase 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Related adhesion focal tyrosine kinase</fullName>
<shortName>RAFTK</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTK2B</name>
<name type="synonym">FAK2</name>
<name type="synonym">PYK2</name>
<name type="synonym">RAFTK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Nature" volume="376" first="737" last="745">
<title>Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions.</title>
<authorList>
<person name="Lev S."/>
<person name="Moreno H."/>
<person name="Martinez R."/>
<person name="Canoll P."/>
<person name="Peles E."/>
<person name="Musacchio J.M."/>
<person name="Plowman G.D."/>
<person name="Rudy B."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="7544443"/>
<dbReference type="DOI" id="10.1038/376737a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION IN REGULATION OF POTASSIUM CHANNELS; PHOSPHORYLATION OF KCNA2 AND SHC1 AND ACTIVATION OF MAPK1/ERK2</scope>
<scope>INTERACTION WITH GRB2</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Genomics" volume="32" first="484" last="486">
<title>Molecular cloning and assignment of FAK2, a novel human focal adhesion kinase, to 8p11.2-p22 by nonisotopic in situ hybridization.</title>
<authorList>
<person name="Herzog H."/>
<person name="Nicholl J."/>
<person name="Hort Y.J."/>
<person name="Sutherland G.R."/>
<person name="Shine J."/>
</authorList>
<dbReference type="PubMed" id="8838818"/>
<dbReference type="DOI" id="10.1006/geno.1996.0149"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="21206" last="21219">
<title>Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily.</title>
<authorList>
<person name="Sasaki H."/>
<person name="Nagura K."/>
<person name="Ishino M."/>
<person name="Tobioka H."/>
<person name="Kotani K."/>
<person name="Sasaki T."/>
</authorList>
<dbReference type="PubMed" id="7673154"/>
<dbReference type="DOI" id="10.1074/jbc.270.36.21206"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="27742" last="27751">
<title>Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain.</title>
<authorList>
<person name="Avraham S."/>
<person name="London R."/>
<person name="Fu Y."/>
<person name="Ota S."/>
<person name="Hiregowdara D."/>
<person name="Li J."/>
<person name="Jiang S."/>
<person name="Pasztor L.M."/>
<person name="White R.A."/>
<person name="Groopman J.E."/>
<person name="Avraham H."/>
</authorList>
<dbReference type="PubMed" id="7499242"/>
<dbReference type="DOI" id="10.1074/jbc.270.46.27742"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="9361" last="9364">
<title>A calcium-dependent tyrosine kinase splice variant in human monocytes. Activation by a two-stage process involving adherence and a subsequent intracellular signal.</title>
<authorList>
<person name="Li X."/>
<person name="Hunter D."/>
<person name="Morris J."/>
<person name="Haskill J.S."/>
<person name="Earp H.S."/>
</authorList>
<dbReference type="PubMed" id="9545257"/>
<dbReference type="DOI" id="10.1074/jbc.273.16.9361"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lymph</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="Nature" volume="383" first="547" last="550">
<title>A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation.</title>
<authorList>
<person name="Dikic I."/>
<person name="Tokiwa G."/>
<person name="Lev S."/>
<person name="Courtneidge S.A."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="8849729"/>
<dbReference type="DOI" id="10.1038/383547a0"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF SRC AND ACTIVATION OF THE MAP KINASE SIGNALING CASCADE</scope>
<scope>INTERACTION WITH SRC</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF TYR-402</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="Science" volume="273" first="792" last="794">
<title>Activation of Pyk2 by stress signals and coupling with JNK signaling pathway.</title>
<authorList>
<person name="Tokiwa G."/>
<person name="Dikic I."/>
<person name="Lev S."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="8670418"/>
<dbReference type="DOI" id="10.1126/science.273.5276.792"/>
</citation>
<scope>FUNCTION IN TNF SIGNALING AND ACTIVATION OF MAPK8/JNK1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="1003" last="1014">
<title>Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions.</title>
<authorList>
<person name="Matsuya M."/>
<person name="Sasaki H."/>
<person name="Aoto H."/>
<person name="Mitaka T."/>
<person name="Nagura K."/>
<person name="Ohba T."/>
<person name="Ishino M."/>
<person name="Takahashi S."/>
<person name="Suzuki R."/>
<person name="Sasaki T."/>
</authorList>
<dbReference type="PubMed" id="9422762"/>
<dbReference type="DOI" id="10.1074/jbc.273.2.1003"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="2338" last="2350">
<title>Identification of a new Pyk2 target protein with Arf-GAP activity.</title>
<authorList>
<person name="Andreev J."/>
<person name="Simon J.-P."/>
<person name="Sabatini D.D."/>
<person name="Kam J."/>
<person name="Plowman G."/>
<person name="Randazzo P.A."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="10022920"/>
<dbReference type="DOI" id="10.1128/MCB.19.3.2338"/>
</citation>
<scope>INTERACTION WITH ASAP2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="J. Cell Biol." volume="149" first="423" last="430">
<title>Suppression of Pyk2 kinase and cellular activities by FIP200.</title>
<authorList>
<person name="Ueda H."/>
<person name="Abbi S."/>
<person name="Zheng C."/>
<person name="Guan J.-L."/>
</authorList>
<dbReference type="PubMed" id="10769033"/>
<dbReference type="DOI" id="10.1083/jcb.149.2.423"/>
</citation>
<scope>INTERACTION WITH RB1CC1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="9784" last="9789">
<title>Nephrocystin interacts with Pyk2, p130(Cas), and tensin and triggers phosphorylation of Pyk2.</title>
<authorList>
<person name="Benzing T."/>
<person name="Gerke P."/>
<person name="Hoepker K."/>
<person name="Hildebrandt F."/>
<person name="Kim E."/>
<person name="Walz G."/>
</authorList>
<dbReference type="PubMed" id="11493697"/>
<dbReference type="DOI" id="10.1073/pnas.171269898"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-402</scope>
<scope>MUTAGENESIS OF PRO-859</scope>
<scope>INTERACTION WITH NPHP1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="29560" last="29570">
<title>The tyrosine kinase Pyk2 regulates Arf1 activity by phosphorylation and inhibition of the Arf-GTPase-activating protein ASAP1.</title>
<authorList>
<person name="Kruljac-Letunic A."/>
<person name="Moelleken J."/>
<person name="Kallin A."/>
<person name="Wieland F."/>
<person name="Blaukat A."/>
</authorList>
<dbReference type="PubMed" id="12771146"/>
<dbReference type="DOI" id="10.1074/jbc.M302278200"/>
</citation>
<scope>FUNCTION IN ASAP1 PHOSPHORYLATION AND REGULATION OF ASAP1 ACTIVITY</scope>
<scope>INTERACTION WITH ASAP1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="42225" last="42233">
<title>Identification and characterization of a novel Pyk2/related adhesion focal tyrosine kinase-associated protein that inhibits alpha-synuclein phosphorylation.</title>
<authorList>
<person name="Takahashi T."/>
<person name="Yamashita H."/>
<person name="Nagano Y."/>
<person name="Nakamura T."/>
<person name="Ohmori H."/>
<person name="Avraham H."/>
<person name="Avraham S."/>
<person name="Yasuda M."/>
<person name="Matsumoto M."/>
</authorList>
<dbReference type="PubMed" id="12893833"/>
<dbReference type="DOI" id="10.1074/jbc.M213217200"/>
</citation>
<scope>INTERACTION WITH SKAP2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="8019" last="8029">
<title>Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions.</title>
<authorList>
<person name="Taniyama Y."/>
<person name="Weber D.S."/>
<person name="Rocic P."/>
<person name="Hilenski L."/>
<person name="Akers M.L."/>
<person name="Park J."/>
<person name="Hemmings B.A."/>
<person name="Alexander R.W."/>
<person name="Griendling K.K."/>
</authorList>
<dbReference type="PubMed" id="14585963"/>
<dbReference type="DOI" id="10.1128/MCB.23.22.8019-8029.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PDPK1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="443" last="448">
<title>Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.</title>
<authorList>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Brill L.M."/>
<person name="Brinker A."/>
<person name="Phung Q.T."/>
<person name="Ericson C."/>
<person name="Sauer K."/>
<person name="Brock A."/>
<person name="Horn D.M."/>
<person name="Schultz P.G."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="12522270"/>
<dbReference type="DOI" id="10.1073/pnas.2436191100"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Exp. Hematol." volume="32" first="365" last="374">
<title>Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products.</title>
<authorList>
<person name="Dylla S.J."/>
<person name="Deyle D.R."/>
<person name="Theunissen K."/>
<person name="Padurean A.M."/>
<person name="Verfaillie C.M."/>
</authorList>
<dbReference type="PubMed" id="15050747"/>
<dbReference type="DOI" id="10.1016/j.exphem.2004.01.001"/>
</citation>
<scope>FUNCTION IN INTEGRIN SIGNALING AND IN REGULATION OF CELL PROLIFERATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>CHARACTERIZATION OF ISOFORM 2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="33315" last="33322">
<title>RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner.</title>
<authorList>
<person name="Park S.Y."/>
<person name="Avraham H.K."/>
<person name="Avraham S."/>
</authorList>
<dbReference type="PubMed" id="15166227"/>
<dbReference type="DOI" id="10.1074/jbc.M313527200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-402</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION IN SRC-MEDIATED PHOSPHORYLATION OF PXN</scope>
<scope>MUTAGENESIS OF LYS-457</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Am. J. Physiol." volume="292" first="C2288" last="C2296">
<title>Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.</title>
<authorList>
<person name="Sahu S.N."/>
<person name="Nunez S."/>
<person name="Bai G."/>
<person name="Gupta A."/>
</authorList>
<dbReference type="PubMed" id="17329398"/>
<dbReference type="DOI" id="10.1152/ajpcell.00503.2006"/>
</citation>
<scope>INTERACTION WITH LPXN AND PTPN12</scope>
<scope>PHOSPHORYLATION AT TYR-402</scope>
<scope>DEPHOSPHORYLATION BY PTPN12</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Eur. J. Immunol." volume="37" first="2326" last="2336">
<title>Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes.</title>
<authorList>
<person name="Hjorthaug H.S."/>
<person name="Aasheim H.C."/>
</authorList>
<dbReference type="PubMed" id="17634955"/>
<dbReference type="DOI" id="10.1002/eji.200737111"/>
</citation>
<scope>FUNCTION IN MIGRATION OF T-LYMPHOCYTES</scope>
<scope>INTERACTION WITH EPHA1; LCK AND PI3-KINASE</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="1935" last="1944">
<title>Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.</title>
<authorList>
<person name="Roberts W.G."/>
<person name="Ung E."/>
<person name="Whalen P."/>
<person name="Cooper B."/>
<person name="Hulford C."/>
<person name="Autry C."/>
<person name="Richter D."/>
<person name="Emerson E."/>
<person name="Lin J."/>
<person name="Kath J."/>
<person name="Coleman K."/>
<person name="Yao L."/>
<person name="Martinez-Alsina L."/>
<person name="Lorenzen M."/>
<person name="Berliner M."/>
<person name="Luzzio M."/>
<person name="Patel N."/>
<person name="Schmitt E."/>
<person name="LaGreca S."/>
<person name="Jani J."/>
<person name="Wessel M."/>
<person name="Marr E."/>
<person name="Griffor M."/>
<person name="Vajdos F."/>
</authorList>
<dbReference type="PubMed" id="18339875"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-5155"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Carcinogenesis" volume="29" first="2096" last="2105">
<title>Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.</title>
<authorList>
<person name="Sun C.K."/>
<person name="Man K."/>
<person name="Ng K.T."/>
<person name="Ho J.W."/>
<person name="Lim Z.X."/>
<person name="Cheng Q."/>
<person name="Lo C.M."/>
<person name="Poon R.T."/>
<person name="Fan S.T."/>
</authorList>
<dbReference type="PubMed" id="18765415"/>
<dbReference type="DOI" id="10.1093/carcin/bgn203"/>
</citation>
<scope>FUNCTION IN CELL ADHESION; MIGRATION; PROLIFERATION; REGULATION OF ACTIN FIBER POLYMERIZATION AND IN ACTIVATION OF SRC; MAPK1/ERK2 AND MAPK3/ERK1</scope>
<scope>INTERACTION WITH SRC</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375; THR-765; SER-839 AND THR-842</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="1802" last="1814">
<title>The atypical Rho GTPase Wrch1 collaborates with the nonreceptor tyrosine kinases Pyk2 and Src in regulating cytoskeletal dynamics.</title>
<authorList>
<person name="Ruusala A."/>
<person name="Aspenstrom P."/>
</authorList>
<dbReference type="PubMed" id="18086875"/>
<dbReference type="DOI" id="10.1128/MCB.00201-07"/>
</citation>
<scope>INTERACTION WITH RHOU</scope>
<scope>FUNCTION IN REORGANIZATION OF ACTIN CYTOSKELETON AND SRC-MEDIATED RHOU PHOSPHORYLATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Nat. Immunol." volume="9" first="880" last="886">
<title>Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating beta2 integrins.</title>
<authorList>
<person name="Xu J."/>
<person name="Gao X.-P."/>
<person name="Ramchandran R."/>
<person name="Zhao Y.-Y."/>
<person name="Vogel S.M."/>
<person name="Malik A.B."/>
</authorList>
<dbReference type="PubMed" id="18587400"/>
<dbReference type="DOI" id="10.1038/ni.1628"/>
</citation>
<scope>FUNCTION DURING LUNG INJURY</scope>
<scope>PHOSPHORYLATION BY MYLK</scope>
<scope>INTERACTION WITH MYLK</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Biochem. J." volume="420" first="49" last="56">
<title>A Pyk2-Vav1 complex is recruited to beta3-adhesion sites to initiate Rho activation.</title>
<authorList>
<person name="Gao C."/>
<person name="Blystone S.D."/>
</authorList>
<dbReference type="PubMed" id="19207108"/>
<dbReference type="DOI" id="10.1042/BJ20090037"/>
</citation>
<scope>FUNCTION IN REGULATION OF ACTIN CYTOSKELETON REORGANIZATION AND ACTIVATION OF RHO FAMILY GTPASES</scope>
<scope>PHOSPHORYLATION AT TYR-402</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH VAV1</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Bioorg. Med. Chem. Lett." volume="19" first="4924" last="4928">
<title>Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells.</title>
<authorList>
<person name="Allen J.G."/>
<person name="Lee M.R."/>
<person name="Han C.Y."/>
<person name="Scherrer J."/>
<person name="Flynn S."/>
<person name="Boucher C."/>
<person name="Zhao H."/>
<person name="O'Connor A.B."/>
<person name="Roveto P."/>
<person name="Bauer D."/>
<person name="Graceffa R."/>
<person name="Richards W.G."/>
<person name="Babij P."/>
</authorList>
<dbReference type="PubMed" id="19648005"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2009.07.084"/>
</citation>
<scope>ROLE IN DISEASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="J. Cell. Physiol." volume="219" first="45" last="56">
<title>Pyk2 mediates endothelin-1 signaling via p130Cas/BCAR3 cascade and regulates human glomerular mesangial cell adhesion and spreading.</title>
<authorList>
<person name="Rufanova V.A."/>
<person name="Alexanian A."/>
<person name="Wakatsuki T."/>
<person name="Lerner A."/>
<person name="Sorokin A."/>
</authorList>
<dbReference type="PubMed" id="19086031"/>
<dbReference type="DOI" id="10.1002/jcp.21649"/>
</citation>
<scope>FUNCTION IN CELL ADHESION AND SPREADING</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH BCAR1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361; SER-375; SER-399; TYR-722; SER-762; TYR-819; TYR-834; SER-839; THR-842; TYR-849 AND SER-866</scope>
<scope>VARIANT [LARGE SCALE ANALYSIS] THR-838</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Cell. Mol. Life Sci." volume="67" first="3893" last="3903">
<title>Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells.</title>
<authorList>
<person name="Shen X."/>
<person name="Xi G."/>
<person name="Radhakrishnan Y."/>
<person name="Clemmons D.R."/>
</authorList>
<dbReference type="PubMed" id="20521079"/>
<dbReference type="DOI" id="10.1007/s00018-010-0411-x"/>
</citation>
<scope>FUNCTION IN IGF1 SIGNALING AND ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1</scope>
<scope>INTERACTION WITH SRC AND GRB2</scope>
<scope>PHOSPHORYLATION AT TYR-402 AND TYR-881</scope>
<scope>MUTAGENESIS OF TYR-881</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="1743" last="1753">
<title>Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival.</title>
<authorList>
<person name="Lim S.T."/>
<person name="Miller N.L."/>
<person name="Nam J.O."/>
<person name="Chen X.L."/>
<person name="Lim Y."/>
<person name="Schlaepfer D.D."/>
</authorList>
<dbReference type="PubMed" id="19880522"/>
<dbReference type="DOI" id="10.1074/jbc.M109.064212"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION AND REGULATION OF P53/TP53 UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="J. Leukoc. Biol." volume="87" first="691" last="701">
<title>The T cell receptor-mediated phosphorylation of Pyk2 tyrosines 402 and 580 occurs via a distinct mechanism than other receptor systems.</title>
<authorList>
<person name="Collins M."/>
<person name="Tremblay M."/>
<person name="Chapman N."/>
<person name="Curtiss M."/>
<person name="Rothman P.B."/>
<person name="Houtman J.C."/>
</authorList>
<dbReference type="PubMed" id="20028775"/>
<dbReference type="DOI" id="10.1189/jlb.0409227"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-402 AND TYR-580 BY FYN AND LCK</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Mol. Immunol." volume="47" first="1665" last="1674">
<title>T cell receptor activation leads to two distinct phases of Pyk2 activation and actin cytoskeletal rearrangement in human T cells.</title>
<authorList>
<person name="Collins M."/>
<person name="Bartelt R.R."/>
<person name="Houtman J.C."/>
</authorList>
<dbReference type="PubMed" id="20381867"/>
<dbReference type="DOI" id="10.1016/j.molimm.2010.03.009"/>
</citation>
<scope>FUNCTION IN T-CELL RECEPTOR-MEDIATED SIGNALING</scope>
<scope>PHOSPHORYLATION AT TYR-402 AND TYR-580</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="14237" last="14245">
<title>Nephrocystin-4 regulates Pyk2-induced tyrosine phosphorylation of nephrocystin-1 to control targeting to monocilia.</title>
<authorList>
<person name="Liebau M.C."/>
<person name="Hopker K."/>
<person name="Muller R.U."/>
<person name="Schmedding I."/>
<person name="Zank S."/>
<person name="Schairer B."/>
<person name="Fabretti F."/>
<person name="Hohne M."/>
<person name="Bartram M.P."/>
<person name="Dafinger C."/>
<person name="Hackl M."/>
<person name="Burst V."/>
<person name="Habbig S."/>
<person name="Zentgraf H."/>
<person name="Blaukat A."/>
<person name="Walz G."/>
<person name="Benzing T."/>
<person name="Schermer B."/>
</authorList>
<dbReference type="PubMed" id="21357692"/>
<dbReference type="DOI" id="10.1074/jbc.M110.165464"/>
</citation>
<scope>INTERACTION WITH NPHP1</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF NPHP1</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E18878" last="E18878">
<title>Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition.</title>
<authorList>
<person name="Sun C.K."/>
<person name="Ng K.T."/>
<person name="Lim Z.X."/>
<person name="Cheng Q."/>
<person name="Lo C.M."/>
<person name="Poon R.T."/>
<person name="Man K."/>
<person name="Wong N."/>
<person name="Fan S.T."/>
</authorList>
<dbReference type="PubMed" id="21533080"/>
<dbReference type="DOI" id="10.1371/journal.pone.0018878"/>
</citation>
<scope>FUNCTION IN REORGANIZATION OF CYTOSKELETON; FORMATION OF MEMBRANE RUFFLES AND CELL MIGRATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Immunol. Res." volume="31" first="267" last="282">
<title>Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function.</title>
<authorList>
<person name="Ostergaard H.L."/>
<person name="Lysechko T.L."/>
</authorList>
<dbReference type="PubMed" id="15888917"/>
<dbReference type="DOI" id="10.1385/IR:31:3:267"/>
</citation>
<scope>REVIEW ON ROLE IN IMMUNITY</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Expert Opin. Ther. Targets" volume="14" first="95" last="108">
<title>Targeting Pyk2 for therapeutic intervention.</title>
<authorList>
<person name="Lipinski C.A."/>
<person name="Loftus J.C."/>
</authorList>
<dbReference type="PubMed" id="20001213"/>
<dbReference type="DOI" id="10.1517/14728220903473194"/>
</citation>
<scope>REVIEW ON FUNCTION; SIGNALING; INTERACTION PARTNERS; ENZYME REGULATION; PHOSPHORYLATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="1007" last="1013">
<title>Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions.</title>
<authorList>
<person name="Schaller M.D."/>
</authorList>
<dbReference type="PubMed" id="20332118"/>
<dbReference type="DOI" id="10.1242/jcs.045112"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Front. Biosci." volume="16" first="568" last="577">
<title>Redox sensitive Pyk2 as a target for therapeutics in breast cancer.</title>
<authorList>
<person name="Felty Q."/>
</authorList>
<dbReference type="PubMed" id="21196189"/>
<dbReference type="DOI" id="10.2741/3706"/>
</citation>
<scope>REVIEW ON ROLE IN DISEASE</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375 AND THR-842</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Bioorg. Med. Chem. Lett." volume="18" first="6071" last="6077">
<title>Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation.</title>
<authorList>
<person name="Walker D.P."/>
<person name="Bi F.C."/>
<person name="Kalgutkar A.S."/>
<person name="Bauman J.N."/>
<person name="Zhao S.X."/>
<person name="Soglia J.R."/>
<person name="Aspnes G.E."/>
<person name="Kung D.W."/>
<person name="Klug-McLeod J."/>
<person name="Zawistoski M.P."/>
<person name="McGlynn M.A."/>
<person name="Oliver R."/>
<person name="Dunn M."/>
<person name="Li J.C."/>
<person name="Richter D.T."/>
<person name="Cooper B.A."/>
<person name="Kath J.C."/>
<person name="Hulford C.A."/>
<person name="Autry C.L."/>
<person name="Luzzio M.J."/>
<person name="Ung E.J."/>
<person name="Roberts W.G."/>
<person name="Bonnette P.C."/>
<person name="Buckbinder L."/>
<person name="Mistry A."/>
<person name="Griffor M.C."/>
<person name="Han S."/>
<person name="Guzman-Perez A."/>
</authorList>
<dbReference type="PubMed" id="18951788"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2008.10.030"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 416-692 IN COMPLEX WITH PF-2318841</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="Biochem. Biophys. Res. Commun." volume="383" first="347" last="352">
<title>Crystal structures of free and ligand-bound focal adhesion targeting domain of Pyk2.</title>
<authorList>
<person name="Lulo J."/>
<person name="Yuzawa S."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="19358827"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2009.04.011"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 861-1009 IN COMPLEX WITH PXN</scope>
<scope>INTERACTION WITH PXN</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="Bioorg. Med. Chem. Lett." volume="19" first="3253" last="3258">
<title>Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity.</title>
<authorList>
<person name="Walker D.P."/>
<person name="Zawistoski M.P."/>
<person name="McGlynn M.A."/>
<person name="Li J.C."/>
<person name="Kung D.W."/>
<person name="Bonnette P.C."/>
<person name="Baumann A."/>
<person name="Buckbinder L."/>
<person name="Houser J.A."/>
<person name="Boer J."/>
<person name="Mistry A."/>
<person name="Han S."/>
<person name="Xing L."/>
<person name="Guzman-Perez A."/>
</authorList>
<dbReference type="PubMed" id="19428251"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2009.04.093"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 416-692 IN COMPLEX WITH INHIBITOR P1E</scope>
<scope>ROLE IN DISEASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="13193" last="13201">
<title>Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.</title>
<authorList>
<person name="Han S."/>
<person name="Mistry A."/>
<person name="Chang J.S."/>
<person name="Cunningham D."/>
<person name="Griffor M."/>
<person name="Bonnette P.C."/>
<person name="Wang H."/>
<person name="Chrunyk B.A."/>
<person name="Aspnes G.E."/>
<person name="Walker D.P."/>
<person name="Brosius A.D."/>
<person name="Buckbinder L."/>
</authorList>
<dbReference type="PubMed" id="19244237"/>
<dbReference type="DOI" id="10.1074/jbc.M809038200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 416-692 IN COMPLEXES WITH ATP ANALOG; PF-431396; BIRB796 AND PF-4618433</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="49">
<citation type="submission" date="2011-07" db="PDB data bank">
<title>Structure of protein tyrosine kinase 2 beta (PTK2B) kinase domain.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 414-692</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLU-359; HIS-698; PRO-808; THR-838 AND LYS-970</scope>
</reference>
<comment type="function">
<text evidence="18 21 22 23 24 25 28 29 30 31 32 34 35 36 38 39 40 41 43 44 45 46 47 48 49">Non-receptor protein-tyrosine kinase that regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading and bone remodeling. Plays a role in the regulation of the humoral immune response, and is required for normal levels of marginal B-cells in the spleen and normal migration of splenic B-cells. Required for normal macrophage polarization and migration towards sites of inflammation. Regulates cytoskeleton rearrangement and cell spreading in T-cells, and contributes to the regulation of T-cell responses. Promotes osteoclastic bone resorption; this requires both PTK2B/PYK2 and SRC. May inhibit differentiation and activity of osteoprogenitor cells. Functions in signaling downstream of integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCR), cytokine, chemokine and growth factor receptors, and mediates responses to cellular stress. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Promotes activation of NOS3. Regulates production of the cellular messenger cGMP. Promotes activation of the MAP kinase signaling cascade, including activation of MAPK1/ERK2, MAPK3/ERK1 and MAPK8/JNK1. Promotes activation of Rho family GTPases, such as RHOA and RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Acts as a scaffold, binding to both PDPK1 and SRC, thereby allowing SRC to phosphorylate PDPK1 at 'Tyr-9, 'Tyr-373', and 'Tyr-376'. Promotes phosphorylation of NMDA receptors by SRC family members, and thereby contributes to the regulation of NMDA receptor ion channel activity and intracellular Ca(2+) levels. May also regulate potassium ion transport by phosphorylation of potassium channel subunits. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ASAP1, NPHP1, KCNA2 and SHC1. Promotes phosphorylation of ASAP2, RHOU and PXN; this requires both SRC and PTK2/PYK2.</text>
</comment>
<comment type="catalytic activity">
<text evidence="17 24 25 30 33 38 39">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="30 33 38 39">Activated in response to stimuli that lead to increased intracellular Ca(2+) levels; this activation is indirect and may be mediated by calcium-mediated production of reactive oxygen species (ROS). Activated by autophosphorylation at Tyr-402; this creates a binding site for SRC family kinases and leads to phosphorylation at additional tyrosine residues. Phosphorylation at Tyr-402, Tyr-579 and Tyr-580 is required for optimal kinase activity. Inhibited by PF-562,271, BIRB796, PF-4618433 and by PF-431396, PF-2318841 and their derivatives. Inhibited by sulfoximine-substituted trifluoromethylpyrimidines. Inhibited by 4-amino and 5-aryl substituted pyridinone compounds.</text>
</comment>
<comment type="subunit">
<text evidence="13 14 18 19 20 21 22 23 26 28 29 31 32 33 34 35 37 38 44 45 47 49 50">Homodimer, or homooligomer. Interacts with SIRPA and SH2D3C. Interacts with ARHGAP10. Interacts with DLG4 (By similarity). Interacts with KCNA2 (By similarity). Interacts with NPHP1, ASAP1, ASAP2, ARHGAP26, SKAP2 and TGFB1I1. The Tyr-402 phosphorylated form interacts with SRC (via SH2 domain) and SRC family members. Forms a signaling complex with EPHA1, LCK and phosphatidylinositol 3-kinase; upon activation by EFNA1. Interacts with GRB2 (via SH2 domain). Interacts with P53/TP53 and MDM2. Interacts with MYLK. Interacts with BCAR1. Interacts with PDPK1. Interacts (hypophosphorylated) with PXN. Interacts with RB1CC1. Interacts with RHOU. Interacts with VAV1. Interacts with LPXN and PTPN12.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298640"/>
<interactant intactId="EBI-4281852">
<id>O75161</id>
<label>NPHP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298640"/>
<interactant intactId="EBI-1638043">
<id>Q7L0Q8</id>
<label>RHOU</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298640"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Peripheral membrane protein</topology>
<orientation>Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location>Cell junction</location>
<location>Focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell projection</location>
<location>Lamellipodium</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cell cortex</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Interaction with NPHP1 induces the membrane-association of the kinase. Colocalizes with integrins at the cell periphery.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14289-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14289-2</id>
<name>2</name>
<name>PYK2H</name>
<sequence type="described" ref="VSP_004981"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="47 51">Most abundant in the brain, with highest levels in amygdala and hippocampus. Low levels in kidney (at protein level). Also expressed in spleen and lymphocytes.</text>
</comment>
<comment type="PTM">
<text evidence="20 25 26 31 35 42 43 44 51">Phosphorylated on tyrosine residues in response to various stimuli that elevate the intracellular calcium concentration; this activation is indirect and may be mediated by production of reactive oxygen species (ROS). Tyr-402 is the major autophosphorylation site, but other kinases can also phosphorylate Tyr-402. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-402 promotes interaction with SRC and SRC family members, leading to phosphorylation at Tyr-579; Tyr-580 and Tyr-881. Phosphorylation at Tyr-881 is important for interaction with GRB2. Phosphorylated on tyrosine residues upon activation of FGR and PKC. Recruitment by NPHP1 to cell matrix adhesions initiates Tyr-402 phosphorylation. In monocytes, adherence to substrata is required for tyrosine phosphorylation and kinase activation. Angiotensin II, thapsigargin and L-alpha-lysophosphatidic acid (LPA) also induce autophosphorylation and increase kinase activity. Phosphorylation by MYLK promotes ITGB2 activation and is thus essential to trigger neutrophil transmigration during lung injury. Dephosphorylated by PTPN12.</text>
</comment>
<comment type="disease">
<text>Aberrant PTK2B/PYK2 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. Elevated PTK2B/PYK2 expression is seen in gliomas, hepatocellular carcinoma, lung cancer and breast cancer.</text>
</comment>
<comment type="miscellaneous">
<text>Promotes bone resorption, and thus PTK2B/PYK2 inhibitors might be used to treat osteoporosis.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the protein kinase superfamily. Tyr protein kinase family. FAK subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="U33284">
<property type="protein sequence ID" value="AAC50203.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L49207">
<property type="protein sequence ID" value="AAB47217.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D45853">
<property type="protein sequence ID" value="BAA08289.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U43522">
<property type="protein sequence ID" value="AAC05330.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S80542">
<property type="protein sequence ID" value="AAB35701.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF311103">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471080">
<property type="protein sequence ID" value="EAW63553.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471080">
<property type="protein sequence ID" value="EAW63555.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471080">
<property type="protein sequence ID" value="EAW63556.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC036651">
<property type="protein sequence ID" value="AAH36651.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC042599">
<property type="protein sequence ID" value="AAH42599.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6057.1">
<molecule id="Q14289-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6058.1">
<molecule id="Q14289-2"/>
</dbReference>
<dbReference type="PIR" id="S60248">
<property type="entry name" value="S60248"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004094.3">
<molecule id="Q14289-1"/>
<property type="nucleotide sequence ID" value="NM_004103.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_775266.1">
<molecule id="Q14289-1"/>
<property type="nucleotide sequence ID" value="NM_173174.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_775267.1">
<molecule id="Q14289-2"/>
<property type="nucleotide sequence ID" value="NM_173175.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_775268.1">
<molecule id="Q14289-1"/>
<property type="nucleotide sequence ID" value="NM_173176.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005273504.1">
<molecule id="Q14289-1"/>
<property type="nucleotide sequence ID" value="XM_005273447.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542743.1">
<molecule id="Q14289-1"/>
<property type="nucleotide sequence ID" value="XM_011544441.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016868703.1">
<molecule id="Q14289-1"/>
<property type="nucleotide sequence ID" value="XM_017013214.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.491322"/>
<dbReference type="UniGene" id="Hs.735450"/>
<dbReference type="PDB" id="2FO6">
<property type="method" value="Model"/>
<property type="chains" value="X=45-350"/>
</dbReference>
<dbReference type="PDB" id="2LK4">
<property type="method" value="NMR"/>
<property type="chains" value="A=871-1005"/>
</dbReference>
<dbReference type="PDB" id="3CC6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=414-692"/>
</dbReference>
<dbReference type="PDB" id="3ET7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="3FZO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="3FZP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="3FZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="3FZS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="3FZT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="3GM1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A/B=861-1009"/>
</dbReference>
<dbReference type="PDB" id="3GM2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A=861-1009"/>
</dbReference>
<dbReference type="PDB" id="3GM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=861-1009"/>
</dbReference>
<dbReference type="PDB" id="3H3C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="3U3F">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C/D=871-1005"/>
</dbReference>
<dbReference type="PDB" id="4EKU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=21-409"/>
</dbReference>
<dbReference type="PDB" id="4H1J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="4H1M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="A=416-692"/>
</dbReference>
<dbReference type="PDB" id="4R32">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=871-1005"/>
</dbReference>
<dbReference type="PDB" id="4XEF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/D=871-1005"/>
</dbReference>
<dbReference type="PDB" id="4XEK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=871-1005"/>
</dbReference>
<dbReference type="PDB" id="4XEV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A/D=871-1005"/>
</dbReference>
<dbReference type="PDB" id="5TO8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A=414-692"/>
</dbReference>
<dbReference type="PDBsum" id="2FO6"/>
<dbReference type="PDBsum" id="2LK4"/>
<dbReference type="PDBsum" id="3CC6"/>
<dbReference type="PDBsum" id="3ET7"/>
<dbReference type="PDBsum" id="3FZO"/>
<dbReference type="PDBsum" id="3FZP"/>
<dbReference type="PDBsum" id="3FZR"/>
<dbReference type="PDBsum" id="3FZS"/>
<dbReference type="PDBsum" id="3FZT"/>
<dbReference type="PDBsum" id="3GM1"/>
<dbReference type="PDBsum" id="3GM2"/>
<dbReference type="PDBsum" id="3GM3"/>
<dbReference type="PDBsum" id="3H3C"/>
<dbReference type="PDBsum" id="3U3F"/>
<dbReference type="PDBsum" id="4EKU"/>
<dbReference type="PDBsum" id="4H1J"/>
<dbReference type="PDBsum" id="4H1M"/>
<dbReference type="PDBsum" id="4R32"/>
<dbReference type="PDBsum" id="4XEF"/>
<dbReference type="PDBsum" id="4XEK"/>
<dbReference type="PDBsum" id="4XEV"/>
<dbReference type="PDBsum" id="5TO8"/>
<dbReference type="ProteinModelPortal" id="Q14289"/>
<dbReference type="SMR" id="Q14289"/>
<dbReference type="BioGrid" id="108480">
<property type="interactions" value="60"/>
</dbReference>
<dbReference type="IntAct" id="Q14289">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="MINT-1211326"/>
<dbReference type="STRING" id="9606.ENSP00000332816"/>
<dbReference type="BindingDB" id="Q14289"/>
<dbReference type="ChEMBL" id="CHEMBL5469"/>
<dbReference type="DrugBank" id="DB01645">
<property type="generic name" value="Genistein"/>
</dbReference>
<dbReference type="DrugBank" id="DB01097">
<property type="generic name" value="Leflunomide"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2181"/>
<dbReference type="iPTMnet" id="Q14289"/>
<dbReference type="PhosphoSitePlus" id="Q14289"/>
<dbReference type="BioMuta" id="PTK2B"/>
<dbReference type="DMDM" id="3183003"/>
<dbReference type="EPD" id="Q14289"/>
<dbReference type="MaxQB" id="Q14289"/>
<dbReference type="PaxDb" id="Q14289"/>
<dbReference type="PeptideAtlas" id="Q14289"/>
<dbReference type="PRIDE" id="Q14289"/>
<dbReference type="TopDownProteomics" id="Q14289-2">
<molecule id="Q14289-2"/>
</dbReference>
<dbReference type="DNASU" id="2185"/>
<dbReference type="Ensembl" id="ENST00000346049">
<molecule id="Q14289-1"/>
<property type="protein sequence ID" value="ENSP00000332816"/>
<property type="gene ID" value="ENSG00000120899"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397501">
<molecule id="Q14289-1"/>
<property type="protein sequence ID" value="ENSP00000380638"/>
<property type="gene ID" value="ENSG00000120899"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420218">
<molecule id="Q14289-2"/>
<property type="protein sequence ID" value="ENSP00000391995"/>
<property type="gene ID" value="ENSG00000120899"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000517339">
<molecule id="Q14289-2"/>
<property type="protein sequence ID" value="ENSP00000427931"/>
<property type="gene ID" value="ENSG00000120899"/>
</dbReference>
<dbReference type="GeneID" id="2185"/>
<dbReference type="KEGG" id="hsa:2185"/>
<dbReference type="UCSC" id="uc003xfn.3">
<molecule id="Q14289-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2185"/>
<dbReference type="DisGeNET" id="2185"/>
<dbReference type="GeneCards" id="PTK2B"/>
<dbReference type="H-InvDB" id="HIX0168898"/>
<dbReference type="HGNC" id="HGNC:9612">
<property type="gene designation" value="PTK2B"/>
</dbReference>
<dbReference type="HPA" id="CAB003850"/>
<dbReference type="HPA" id="HPA026091"/>
<dbReference type="HPA" id="HPA026276"/>
<dbReference type="MIM" id="601212">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14289"/>
<dbReference type="OpenTargets" id="ENSG00000120899"/>
<dbReference type="PharmGKB" id="PA33956"/>
<dbReference type="eggNOG" id="KOG4257">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZH9Y">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000069938"/>
<dbReference type="HOVERGEN" id="HBG004018"/>
<dbReference type="InParanoid" id="Q14289"/>
<dbReference type="KO" id="K05871"/>
<dbReference type="OMA" id="VKTCKKD"/>
<dbReference type="OrthoDB" id="EOG091G03BN"/>
<dbReference type="PhylomeDB" id="Q14289"/>
<dbReference type="TreeFam" id="TF316643"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-391160">
<property type="pathway name" value="Signal regulatory protein (SIRP) family interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-451927">
<property type="pathway name" value="Interleukin-2 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q14289"/>
<dbReference type="SIGNOR" id="Q14289"/>
<dbReference type="ChiTaRS" id="PTK2B">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q14289"/>
<dbReference type="GeneWiki" id="PTK2B"/>
<dbReference type="GenomeRNAi" id="2185"/>
<dbReference type="PRO" id="PR:Q14289"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000120899"/>
<dbReference type="CleanEx" id="HS_PTK2B"/>
<dbReference type="ExpressionAtlas" id="Q14289">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14289">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0097440">
<property type="term" value="C:apical dendrite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030426">
<property type="term" value="C:growth cone"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0017146">
<property type="term" value="C:NMDA selective glutamate receptor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0043423">
<property type="term" value="F:3-phosphoinositide-dependent protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004683">
<property type="term" value="F:calmodulin-dependent protein kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0004972">
<property type="term" value="F:NMDA glutamate receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032403">
<property type="term" value="F:protein complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090630">
<property type="term" value="P:activation of GTPase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042976">
<property type="term" value="P:activation of Janus kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043534">
<property type="term" value="P:blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045453">
<property type="term" value="P:bone resorption"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0071498">
<property type="term" value="P:cellular response to fluid shear stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071300">
<property type="term" value="P:cellular response to retinoic acid"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070098">
<property type="term" value="P:chemokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048041">
<property type="term" value="P:focal adhesion assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014009">
<property type="term" value="P:glial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035235">
<property type="term" value="P:ionotropic glutamate receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0060292">
<property type="term" value="P:long term synaptic depression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060291">
<property type="term" value="P:long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002315">
<property type="term" value="P:marginal zone B cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030502">
<property type="term" value="P:negative regulation of bone mineralization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010656">
<property type="term" value="P:negative regulation of muscle cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045638">
<property type="term" value="P:negative regulation of myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0043267">
<property type="term" value="P:negative regulation of potassium ion transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031175">
<property type="term" value="P:neuron projection development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001556">
<property type="term" value="P:oocyte maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030838">
<property type="term" value="P:positive regulation of actin filament polymerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000538">
<property type="term" value="P:positive regulation of B cell chemotaxis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001954">
<property type="term" value="P:positive regulation of cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000573">
<property type="term" value="P:positive regulation of DNA biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010595">
<property type="term" value="P:positive regulation of endothelial cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000463">
<property type="term" value="P:positive regulation of excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043507">
<property type="term" value="P:positive regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051000">
<property type="term" value="P:positive regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045860">
<property type="term" value="P:positive regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000060">
<property type="term" value="P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051968">
<property type="term" value="P:positive regulation of synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0045727">
<property type="term" value="P:positive regulation of translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006461">
<property type="term" value="P:protein complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:2000249">
<property type="term" value="P:regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050848">
<property type="term" value="P:regulation of calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030155">
<property type="term" value="P:regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008360">
<property type="term" value="P:regulation of cell shape"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030826">
<property type="term" value="P:regulation of cGMP biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010752">
<property type="term" value="P:regulation of cGMP-mediated signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000114">
<property type="term" value="P:regulation of establishment of cell polarity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032960">
<property type="term" value="P:regulation of inositol trisphosphate biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010758">
<property type="term" value="P:regulation of macrophage chemotaxis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000310">
<property type="term" value="P:regulation of NMDA receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:2000058">
<property type="term" value="P:regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051279">
<property type="term" value="P:regulation of release of sequestered calcium ion into cytosol"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051592">
<property type="term" value="P:response to calcium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051591">
<property type="term" value="P:response to cAMP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042220">
<property type="term" value="P:response to cocaine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009749">
<property type="term" value="P:response to glucose"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009725">
<property type="term" value="P:response to hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042542">
<property type="term" value="P:response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035902">
<property type="term" value="P:response to immobilization stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010226">
<property type="term" value="P:response to lithium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009612">
<property type="term" value="P:response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006970">
<property type="term" value="P:response to osmotic stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006950">
<property type="term" value="P:response to stress"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007172">
<property type="term" value="P:signal complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002040">
<property type="term" value="P:sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043149">
<property type="term" value="P:stress fiber assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.80.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR019749">
<property type="entry name" value="Band_41_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR014352">
<property type="entry name" value="FERM/acyl-CoA-bd_prot_3-hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR019748">
<property type="entry name" value="FERM_central"/>
</dbReference>
<dbReference type="InterPro" id="IPR000299">
<property type="entry name" value="FERM_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR005189">
<property type="entry name" value="Focal_adhesion_kin_target_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH_dom-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR030610">
<property type="entry name" value="PTK2B"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-rel_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24418:SF338">
<property type="entry name" value="PTHR24418:SF338"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00373">
<property type="entry name" value="FERM_M"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03623">
<property type="entry name" value="Focal_AT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="ProDom" id="PD006413">
<property type="entry name" value="Focal_adhesion_target_reg"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00295">
<property type="entry name" value="B41"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47031">
<property type="entry name" value="SSF47031"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50729">
<property type="entry name" value="SSF50729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF68993">
<property type="entry name" value="SSF68993"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50057">
<property type="entry name" value="FERM_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="chain" description="Protein-tyrosine kinase 2-beta" id="PRO_0000088081">
<location>
<begin position="1"/>
<end position="1009"/>
</location>
</feature>
<feature type="domain" description="FERM" evidence="15">
<location>
<begin position="39"/>
<end position="359"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="16">
<location>
<begin position="425"/>
<end position="683"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="431"/>
<end position="439"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="503"/>
<end position="509"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TGFB1I1" evidence="12">
<location>
<begin position="801"/>
<end position="1009"/>
</location>
</feature>
<feature type="region of interest" description="Focal adhesion targeting (FAT)">
<location>
<begin position="868"/>
<end position="1009"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="702"/>
<end position="767"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="831"/>
<end position="869"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="16 17">
<location>
<position position="549"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="457"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="361"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 10 11">
<location>
<position position="375"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="399"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="20 25 26 35 42 43 44">
<location>
<position position="402"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC, LYN and LCK" evidence="12">
<location>
<position position="579"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC, LYN and LCK" evidence="42 43">
<location>
<position position="580"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="722"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="762"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="765"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="819"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="834"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10">
<location>
<position position="839"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 10 11">
<location>
<position position="842"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="849"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="866"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="44">
<location>
<position position="881"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004981" evidence="52">
<location>
<begin position="739"/>
<end position="780"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56175011." id="VAR_041687" evidence="27">
<original>Q</original>
<variation>E</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35174236." id="VAR_041688" evidence="27">
<original>R</original>
<variation>H</variation>
<location>
<position position="698"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55747955." id="VAR_041689" evidence="27">
<original>L</original>
<variation>P</variation>
<location>
<position position="808"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs751019." id="VAR_020284" evidence="10 27">
<original>K</original>
<variation>T</variation>
<location>
<position position="838"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56263944." id="VAR_041690" evidence="27">
<original>E</original>
<variation>K</variation>
<location>
<position position="970"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation. Abolishes interaction with SRC." evidence="49">
<original>Y</original>
<variation>F</variation>
<location>
<position position="402"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NPHP1." evidence="20">
<original>P</original>
<variation>A</variation>
<location>
<position position="859"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site. Strongly reduced interaction with GRB2." evidence="44">
<original>Y</original>
<variation>F</variation>
<location>
<position position="881"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA08289/AAC05330." ref="3" evidence="53">
<original>A</original>
<variation>G</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB47217." ref="2" evidence="53">
<original>G</original>
<variation>P</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC05330." ref="3" evidence="53">
<original>F</original>
<variation>L</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB47217." ref="2" evidence="53">
<original>R</original>
<variation>G</variation>
<location>
<position position="780"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAH36651." ref="8" evidence="53">
<original>V</original>
<variation>M</variation>
<location>
<position position="985"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="38"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="52"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="55"/>
<end position="62"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="67"/>
<end position="76"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="77"/>
<end position="80"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="87"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="90"/>
<end position="99"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="102"/>
<end position="105"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="111"/>
<end position="117"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="119"/>
<end position="121"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="124"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="127"/>
<end position="133"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="141"/>
<end position="144"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="148"/>
<end position="165"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="166"/>
<end position="169"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="172"/>
<end position="186"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="194"/>
<end position="196"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="198"/>
<end position="207"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="210"/>
<end position="212"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="216"/>
<end position="221"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="224"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="243"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="263"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="277"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="285"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="297"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="302"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="310"/>
<end position="313"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="314"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="317"/>
<end position="322"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="331"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="338"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="356"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="425"/>
<end position="433"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="435"/>
<end position="445"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="447"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="451"/>
<end position="458"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="461"/>
<end position="463"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="465"/>
<end position="481"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="489"/>
<end position="493"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="495"/>
<end position="497"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="499"/>
<end position="503"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="510"/>
<end position="517"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="518"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="523"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="546"/>
<end position="548"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="552"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="555"/>
<end position="559"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="562"/>
<end position="565"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="570"/>
<end position="572"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="589"/>
<end position="591"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="594"/>
<end position="599"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="604"/>
<end position="619"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="620"/>
<end position="622"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="625"/>
<end position="628"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="631"/>
<end position="633"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="634"/>
<end position="640"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="652"/>
<end position="661"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="666"/>
<end position="668"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="672"/>
<end position="691"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="879"/>
<end position="897"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="898"/>
<end position="900"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="903"/>
<end position="905"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="906"/>
<end position="927"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="928"/>
<end position="930"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="933"/>
<end position="962"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="963"/>
<end position="965"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="969"/>
<end position="1004"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CC6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FZO"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FZR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GM3"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EKU"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XEK"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5TO8"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P70600"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QVP9"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00084"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10022920"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10769033"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11493697"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12771146"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12893833"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14585963"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15050747"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15166227"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17329398"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17634955"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18086875"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18339875"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18587400"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18765415"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18951788"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19086031"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19207108"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19244237"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19358827"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19428251"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19648005"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19880522"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20001213"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20028775"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20381867"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20521079"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21357692"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21533080"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7544443"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8670418"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8849729"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9422762"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9545257"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9545257"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000305"/>
<sequence length="1009" mass="115875" checksum="420B21046274E7C2" modified="1998-07-15" version="2">
MSGVSEPLSRVKLGTLRRPEGPAEPMVVVPVDVEKEDVRILKVCFYSNSFNPGKNFKLVK
CTVQTEIREIITSILLSGRIGPNIRLAECYGLRLKHMKSDEIHWLHPQMTVGEVQDKYEC
LHVEAEWRYDLQIRYLPEDFMESLKEDRTTLLYFYQQLRNDYMQRYASKVSEGMALQLGC
LELRRFFKDMPHNALDKKSNFELLEKEVGLDLFFPKQMQENLKPKQFRKMIQQTFQQYAS
LREEECVMKFFNTLAGFANIDQETYRCELIQGWNITVDLVIGPKGIRQLTSQDAKPTCLA
EFKQIRSIRCLPLEEGQAVLQLGIEGAPQALSIKTSSLAEAENMADLIDGYCRLQGEHQG
SLIIHPRKDGEKRNSLPQIPMLNLEARRSHLSESCSIESDIYAEIPDETLRRPGGPQYGI
AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN
LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL
ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR
RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR
CWDYDPSDRPRFTELVCSLSDVYQMEKDIAMEQERNARYRTPKILEPTAFQEPPPKPSRP
KYRPPPQTNLLAPKLQFQVPEGLCASSPTLTSPMEYPSPVNSLHTPPLHRHNVFKRHSMR
EEDFIQPSSREEAQQLWEAEKVKMRQILDKQQKQMVEDYQWLRQEEKSLDPMVYMNDKSP
LTPEKEVGYLEFTGPPQKPPRLGAQSIQPTANLDRTDDLVYLNVMELVRAVLELKNELCQ
LPPEGYVVVVKNVGLTLRKLIGSVDDLLPSLPSSSRTEIEGTQKLLNKDLAELINKMRLA
QQNAVTSLSEECKRQMLTASHTLAVDAKNLLDAVDQAKVLANLAHPPAE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>